Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.63 -0.05 (-6.94%)
As of: Oct 22, 2026 · 3:59 PM EDT

Bluejay Diagnostics (BJDX) Notes Payables (2020 - 2024)

Updated

Bluejay Diagnostics (BJDX) reported Notes Payables of $147,440 for Q2 2024.

Analysis

Bluejay Diagnostics (BJDX) Notes Payables (2020 - 2024) Analysis & Trends

At the end of FY2020, Bluejay Diagnostics posted Notes Payables of $1.04 million.

  • The Q2 2024 figure ranks as the highest quarterly Notes Payables since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn
10 Bluejay Diagnostics 1.33 Mn -20.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 147,440.00
Dec 31, 2020 1.04 Mn
API Access

Bluejay Diagnostics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=BJDX&period=max&api_key=YOUR_API_KEY